- Surviving the COVID-19 pandemic: early response of a gynecologic oncology unit in Singapore
-
Lim YH, Chay WY, Wong WL
- KMID: 2512047
- J Gynecol Oncol.
- 2020 Nov;31(6):e77.
- doi: 10.3802/jgo.2020.31.e77
-
- CITED
-
- Close
- SHARE
-
- Close
- Comments on: Fertility-sparing treatment for intramucous, moderately differentiated, endometrioid endometrial cancer: a Gynecologic Cancer Inter-Group (GCIG) study
-
Park JY
- KMID: 2512074
- J Gynecol Oncol.
- 2020 Nov;31(6):e96.
- doi: 10.3802/jgo.2020.31.e96
-
- CITED
-
- Close
- SHARE
-
- Close
- Olaparib and bevacizumab in frontline maintenance of ovarian cancer: an over reliance in unpowered subgroup analysis of the PAOLA-1 trial?
-
Paulino E, Melo ACd
- KMID: 2512073
- J Gynecol Oncol.
- 2020 Nov;31(6):e95.
- doi: 10.3802/jgo.2020.31.e95
-
- CITED
-
- Close
- SHARE
-
- Close
- Uterine clear cell carcinoma risk in White versus non-White US subpopulations: does race matter?
-
Chow S, Wong D, Liao CI, Mann A, Tian C, Darcy KM, Chan JK
- KMID: 2512051
- J Gynecol Oncol.
- 2020 Nov;31(6):e81.
- doi: 10.3802/jgo.2020.31.e81
Objective: To determine incidence rates of uterine clear cell carcinoma among non-White US subpopulations. Methods: Data from the United States Cancer Statistics and National Cancer Database from 2004 to 2016 were... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of the optimal sequence of adjuvant chemotherapy and radiation therapy in the treatment of advanced endometrial cancer
-
McEachron J, Zhou N, Spencer C, Shanahan L, Chatterton C, Singhal P, Lee YC
- KMID: 2512055
- J Gynecol Oncol.
- 2020 Nov;31(6):e90.
- doi: 10.3802/jgo.2020.31.e90
Objective: The optimal sequence of adjuvant chemoradiation in the treatment of advanced endometrial carcinoma (EC) remains unclear. We sought to evaluate the outcomes of patients treated with chemoradiation in sandwich... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups
-
Bogani G, Apolone G, Ditto A, Scambia G, Panici PB, Angioli R, Pignata S, Greggi S, Scollo P, Delia M, Franchi M, Martinelli F, Signorelli M, Lopez S, Donato VD, Valabrega G, Ferrandina G, Palaia I, Bergamini A, Bocciolone L, Savarese A, Ghezzi F, Casarin J, Pinelli C, Trojano V, Chiantera V, Giorda G, Sopracordevole F, Malzoni M, Salerno G, Sartori E, Testa A, Zannoni G, Zullo F, Vizza E, Trojano G, Chiantera A, Raspagliesi F
- KMID: 2512057
- J Gynecol Oncol.
- 2020 Nov;31(6):e92.
- doi: 10.3802/jgo.2020.31.e92
Objective: Coronavirus disease 2019 (COVID-19) has caused rapid and drastic changes in cancer management. The Italian Society of Gynecology and Obstetrics (SIGO), and the Multicenter Italian Trials in Ovarian cancer... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of stage II endometrial cancer and subsequent oncologic outcomes: a National Cancer Database study
-
Vetter MH, Bixel K, Felix AS
- KMID: 2512053
- J Gynecol Oncol.
- 2020 Nov;31(6):e84.
- doi: 10.3802/jgo.2020.31.e84
Objective: The management of stage II endometrial cancer (EC) is challenging due to the wide variation in surgical practice and adjuvant treatment recommendations. We sought to describe the treatment patterns... -
- CITED
-
- Close
- SHARE
-
- Close
- Reclassification of BRCA1 and BRCA2 variants found in ovarian epithelial, fallopian tube, and primary peritoneal cancers
-
Ha HI, Ryu JS, Shim H, Kong SY, Lim MC
- KMID: 2512052
- J Gynecol Oncol.
- 2020 Nov;31(6):e83.
- doi: 10.3802/jgo.2020.31.e83
Objective: We investigated the proportions of and reclassified BRCA1/2 variants of unknown significance (VUS) in Korean patients with epithelial ovarian, tubal, and primary peritoneal cancers. Methods: Data from 805 patients who... -
- CITED
-
- Close
- SHARE
-
- Close
- High expression of maternal embryonic leucine-zipper kinase (MELK) impacts clinical outcomes in patients with ovarian cancer and its inhibition suppresses ovarian cancer cells growth ex vivo
-
Ikeda Y, Sato S, Yabuno A, Shintani D, Ogasawara A, Miwa M, Zewde M, Miyamoto T, Fujiwara K, Nakamura Y, Hasegawa K
- KMID: 2512058
- J Gynecol Oncol.
- 2020 Nov;31(6):e93.
- doi: 10.3802/jgo.2020.31.e93
Objective: Maternal embryonic leucine zipper kinase (MELK) is receiving an attention as a therapeutic target in various types of cancers. In this study, we aimed to evaluate the prognostic significance... -
- CITED
-
- Close
- SHARE
-
- Close
- Kallikrein 5 overexpression is associated with poor prognosis in uterine cervical cancer
-
Chang JS, Kim N, Kim JY, Do SI, Cho Y, Kim HS, Kim YB
- KMID: 2512048
- J Gynecol Oncol.
- 2020 Nov;31(6):e78.
- doi: 10.3802/jgo.2020.31.e78
Objective: Kallikrein 5 (KLK5), which is frequently observed in normal cervico-vaginal fluid, is known to be related to prognosis in several solid tumors. We investigated the prognostic significance of KLK5... -
- CITED
-
- Close
- SHARE
-
- Close
- Feasibility and safety of fertilitysparing surgery in epithelial ovarian cancer with dense adhesion: a longterm result from a single institution
-
Baek MH, Park JY, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT
- KMID: 2512054
- J Gynecol Oncol.
- 2020 Nov;31(6):e85.
- doi: 10.3802/jgo.2020.31.e85
Objective: We investigated the feasibility and safety of fertility-sparing surgery (FSS) in patients with epithelial ovarian cancer (EOC) with dense adhesions. Methods: Patients were divided into cases with and without dense... -
- CITED
-
- Close
- SHARE
-
- Close
- Surgical or imaging lymph node assessment in locally advanced cervical cancer: a systematic review and meta-analysis
-
Delara R, Yang J, Buckner-Petty S, Magtibay P, Butler K
- KMID: 2512049
- J Gynecol Oncol.
- 2020 Nov;31(6):e79.
- doi: 10.3802/jgo.2020.31.e79
Objective: To evaluate the survival impact of imaging vs surgical nodal assessment in patients with cervical cancer stage IB2–IVA prior to definitive chemoradiotherapy (CRT). Methods: PubMed, MEDLINE, Cochrane Library, and ClinicalTrials.gov... -
- CITED
-
- Close
- SHARE
-
- Close
- Does adenocarcinoma have a worse prognosis than squamous cell carcinoma in patients with cervical cancer? A real-world study with a propensity score matching analysis
-
Pan X, Yang W, Wen Z, Li F, Tong L, Tang W
- KMID: 2512050
- J Gynecol Oncol.
- 2020 Nov;31(6):e80.
- doi: 10.3802/jgo.2020.31.e80
Objective: To compare survival outcomes between cervical adenocarcinoma (ADC) and squamous cell carcinoma (SCC) using a propensity score matching (PSM) analysis based on the Surveillance, Epidemiology, and End Results (SEER)... -
- CITED
-
- Close
- SHARE
-
- Close
- High mobility group box 3 promotes cervical cancer proliferation by regulating Wnt/β-catenin pathway
-
Zhuang S, Yu X, Lu M, Li Y, Ding N, Ding Y
- KMID: 2512056
- J Gynecol Oncol.
- 2020 Nov;31(6):e91.
- doi: 10.3802/jgo.2020.31.e91
Objective: High mobility group box 3 (HMGB3) plays an important role in the development of various cancer. This study aims to explore whether HMGB3 regulates cervical cancer (CC) progression and... -
- CITED
-
- Close
- SHARE
-
- Close
- The post-progression survival of patients with recurrent or persistent ovarian clear cell carcinoma: results from a randomized phase III study in JGOG3017/GCIG
-
Kondo E, Tabata T, Suzuki N, Aoki D, Yahata H, Kotera Y, Tokuyama O, Fujiwara K, Kimura E, Terauchi F, Sumi T, Okamoto A, Yaegashi N, Enomoto T, Sugiyama T
- KMID: 2512059
- J Gynecol Oncol.
- 2020 Nov;31(6):e94.
- doi: 10.3802/jgo.2020.31.e94
Objective: In this study we sought to investigate the clinical factors that affect postprogression survival (PPS) in patients with recurrent or persistent clear cell carcinoma (CCC). We utilized the JGOG3017/Gynecological Cancer... -
- CITED
-
- Close
- SHARE
-
- Close
